Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Card Fail ; 23(1): 29-35, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27742455

ABSTRACT

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a frequent cause of pulmonary hypertension (PH) that is not easy to differentiate from precapillary PH. We aimed to determine whether the characteristic features of the patients may help differentiate between HFpEF and precapillary PH. METHODS AND RESULTS: Clinical and echocardiographic parameters were analyzed in 156 patients referred to our PH referral center. Right heart catheterization identified 78 PH-HFpEF patients and 78 with precapillary PH. Compared with precapillary PH, PH-HFpEF patients were older, with a smaller proportion of women, a higher proportion of hypertension, diabetes mellitus, atrial fibrillation and sleep apnea syndrome, and a higher body mass index. On echocardiography, PH-HFpEF patients had higher left ventricular mass index, higher left atrial area, and smaller right ventricular end-diastolic area. Following multivariate analysis, a model predicting the probability of PH-HFpEF was built with history of diabetes mellitus, presence of atrial fibrillation, left atrial area, right ventricular end-diastolic area, and left ventricular mass index. The score was internally validated using bootstrap method (area under the curve 0.93 [95% confidence interval 0.918-0.938]). A score <5 ruled out PH-HFpEF. CONCLUSION: A score including clinical and echocardiographic criteria may help physicians to identify PH-HFpEF from precapillary PH.


Subject(s)
Echocardiography/methods , Heart Failure/complications , Heart Ventricles/diagnostic imaging , Hypertension, Pulmonary/diagnosis , Pulmonary Wedge Pressure/physiology , Stroke Volume/physiology , Aged , Cardiac Catheterization , Female , Follow-Up Studies , Heart Failure/diagnosis , Heart Failure/physiopathology , Heart Ventricles/physiopathology , Humans , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Male , Middle Aged , Prognosis , Retrospective Studies
2.
Hypertension ; 62(2): 352-8, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23798345

ABSTRACT

Exposure to diesel exhaust was recently identified as an important cardiovascular risk factor, but whether it impairs nitric oxide (NO)-mediated endothelial function and increases production of reactive oxygen species (ROS) in endothelial cells is not known. We tested these hypotheses in a randomized, controlled, crossover study in healthy male volunteers exposed to ambient and polluted air (n=12). The effects of skin microvascular hyperemic provocative tests, including local heating and iontophoresis of acetylcholine and sodium nitroprusside, were assessed using a laser Doppler imager. Before local heating, skin was pretreated by iontophoresis of either a specific NO-synthase inhibitor (L-N-arginine-methyl-ester) or a saline solution (Control). ROS production was measured by chemiluminescence using the lucigenin technique in human umbilical vein endothelial cells preincubated with serum from 5 of the subjects. Exposure to diesel exhaust reduced acetylcholine-induced vasodilation (P<0.01) but did not affect vasodilation with sodium nitroprusside. Moreover, the acetylcholine/sodium nitroprusside vasodilation ratio decreased from 1.51 ± 0.1 to 1.06 ± 0.07 (P<0.01) and was correlated to inhaled particulate matter 2.5 (r=-0.55; P<0.01). NO-mediated skin thermal vasodilatation decreased from 466 ± 264% to 29 ± 123% (P<0.05). ROS production was increased after polluted air exposure (P<0.01) and was correlated with the total amount of inhaled particulate matter <2.5 µm (PM2.5). In healthy subjects, acute experimental exposure to diesel exhaust impaired NO-mediated endothelial vasomotor function and promoted ROS generation in endothelial cells. Increased PM2.5 inhalation enhances microvascular dysfunction and ROS production.


Subject(s)
Endothelium, Vascular/physiology , Nitric Oxide/physiology , Oxidative Stress , Vasodilation/drug effects , Vehicle Emissions/toxicity , Adult , Air Pollution/adverse effects , Cross-Over Studies , Hemodynamics/drug effects , Humans , Male , Microcirculation/drug effects , Reactive Oxygen Species/metabolism , Respiration/drug effects , Superoxides/metabolism
3.
J Cardiovasc Pharmacol ; 61(5): 361-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23318989

ABSTRACT

BACKGROUND: Decreased endothelial Nitric oxide (NO) bioavailability is one of the earliest events of endothelial dysfunction. Assessment of microvascular blood flow using a Laser Doppler Imager during local noninvasive administration of L-N-Arginine-Methyl-Ester (L-NAME) by skin iontophoresis may help discriminate the relative contributions of NO and non-NO pathways during a skin thermal hyperemic test. METHODS: In healthy nonsmokers, the effects of thermal vasodilation and sodium nitroprusside-mediated vasodilation were tested on skin pretreated with 0.9% saline solution, 2% L-NAME iontophoresis (n = 12), or intradermal injection of 25 nmol L-NAME (n = 10). The effects of L-NAME iontophoresis were also measured in a group of smokers (n = 10). RESULTS: L-NAME iontophoresis and intradermal injection of L-NAME decreased the skin response to local heating to a similar degree (-41% ± 4% vs. -44% ± 6%). L-NAME iontophoresis site-to-site and day-to-day coefficients of correlation were 0.83 and 0.76, respectively (P < 0.01). The site-to-site and day-to-day coefficients of correlation of L-NAME injection were lower than those of iontophoresis at 0.66 (P < 0.05) and 0.12, respectively (P = not significant). Sodium nitroprusside-induced skin hyperemia was not affected by L-NAME administration. L-NAME iontophoresis-mediated inhibition of skin thermal hyperemia was greater in smokers than in nonsmokers (P < 0.05). CONCLUSIONS: Laser Doppler Imager assessment of skin thermal hyperemia after L-NAME iontophoresis provides a reproducible and selective bedside method of qualitatively analyzing the contribution of the NO pathway to microvascular vasomotor function.


Subject(s)
Enzyme Inhibitors/administration & dosage , Hyperemia/physiopathology , Hyperthermia, Induced , Iontophoresis , NG-Nitroarginine Methyl Ester/administration & dosage , Skin/blood supply , Vasodilation/physiology , Adult , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Feasibility Studies , Humans , Injections, Intradermal , Laser-Doppler Flowmetry , Male , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Nitric Oxide Donors/administration & dosage , Nitroprusside/administration & dosage , Reproducibility of Results , Signal Transduction , Smoking/adverse effects , Smoking/physiopathology , Vasodilation/drug effects , Young Adult
4.
J Cardiovasc Pharmacol ; 60(6): 530-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22967987

ABSTRACT

BACKGROUND: Epidemiological and clinical studies have shown that traffic-related air pollution and, particularly, diesel exhaust particles (DEP) are strongly linked to cardiovascular mortality. METHODS: Vascular toxicity was studied by assessing vasomotor responses of aortas isolated from normotensive Wistar rats exposed in vitro to DEP (DEP suspension and aqueous DEP extract). In vivo experiments were performed on Wistar rats and spontaneously hypertensive rats (SHRs) exposed for 4 weeks via intratracheal instillation to either DEP or saline vehicle. After killing, vascular responses to acetylcholine (ACh) or sodium nitroprusside were assessed in vitro and the expression of p22phox, a major nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit, was studied by real-time quantitative polymerase chain reaction. RESULTS: In aortas from Wistar rats, in vitro DEP incubation (both preparations) markedly inhibited the relaxations to ACh and slightly to sodium nitroprusside; this effect was reversed in the presence of superoxide dismutase. In contrast, in aortas from in vivo-exposed animals, ACh-induced relaxations were only significantly impaired in the SHR group, accompanied with a significant upregulation of p22phox and no change in systolic blood pressure. CONCLUSIONS: Although in vitro exposure to DEP produces a vascular oxidative stress, repeated in vivo exposures to DEP only impair vascular function in SHR, via an upregulation of p22phox. This suggests a synergistic effect on endothelial dysfunction between particulate air pollution and hypertension.


Subject(s)
Aorta, Thoracic/drug effects , Hypertension/physiopathology , Oxidative Stress/drug effects , Particulate Matter/toxicity , Vasodilation/drug effects , Vehicle Emissions/toxicity , Animals , Aorta, Thoracic/metabolism , Blood Pressure , Disease Models, Animal , Dose-Response Relationship, Drug , Hypertension/genetics , Hypertension/metabolism , Male , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , Rats , Rats, Inbred SHR , Rats, Wistar , Real-Time Polymerase Chain Reaction , Up-Regulation , Vasodilator Agents/pharmacology
5.
J Hypertens ; 26(2): 284-94, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18192843

ABSTRACT

BACKGROUND: The peripheral chemoreflex contributes to cardiovascular regulation and represents the first line of defence against hypoxia. The effects of nicotine on chemoreflex regulation in non-smoking humans are unknown. METHOD: We conducted a prospective, randomized, crossover, and placebo-controlled study in 20 male non-smokers to test the hypothesis that nicotine increases chemoreflex sensitivity. The effects of two intakes of 2 mg nicotine tabs and placebo on sympathetic nerve activity to muscle circulation (muscle sympathetic nerve activity; MSNA), minute ventilation (Ve), blood pressure and heart rate were assessed during normoxia, moderate isocapnic hypoxia, hyperoxic hypercapnia and an isometric handgrip in 10 subjects. Maximal end-expiratory apnoeas were performed at baseline and at the end of the fifth minute of hypoxia. In a second experimental setting, we studied the ventilatory response to a more marked isocapnic hypoxia in 10 other volunteers. RESULTS: Mean MSNA and Ve were not modified by nicotine during the 5 min of normoxia or moderate hypoxia. In the presence of nicotine MSNA was related to oxygen desaturation (P < 0.01). The sympathoexcitatory effects of nicotine became especially evident when apnoeas achieved oxygen saturations less than 85% (511 +/- 44% increase in MSNA after the first intake, and 436 +/- 43% increase after the second intake versus 387 +/- 56% and 338 +/- 31% with placebo, respectively, P < 0.05). Nicotine also increased the ventilatory response compared with placebo when oxygen saturation decreased to less than 85% (P < 0.05). CONCLUSION: This is the first study to demonstrate that nicotine increases peripheral chemoreflex sensitivity to large reductions in arterial oxygen content in healthy non-smokers.


Subject(s)
Chemoreceptor Cells/drug effects , Ganglionic Stimulants/pharmacology , Heart Rate/drug effects , Hypoxia/physiopathology , Nicotine/pharmacology , Respiration/drug effects , Adult , Apnea/physiopathology , Blood Pressure/drug effects , Blood Pressure/physiology , Carotid Body/drug effects , Cross-Over Studies , Electrocardiography/drug effects , Heart Rate/physiology , Humans , Male , Prospective Studies
6.
Am J Physiol Heart Circ Physiol ; 294(1): H322-9, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17965284

ABSTRACT

cAMP plays an important role in peripheral chemoreflex function in animals. We tested the hypothesis that the phosphodiesterase inhibitor and inotropic medication enoximone increases peripheral chemoreflex function in humans. In a single-blind, randomized, placebo-controlled crossover study of 15 men, we measured ventilatory, muscle sympathetic nerve activity, and hemodynamic responses to 5 min of isocapnic hypoxia, 5 min of hyperoxic hypercapnia, and 3 min of isometric handgrip exercise, separated by 1 wk, with enoximone and placebo administration. Enoximone increased cardiac output by 120 +/- 3.7% from baseline (P < 0.001); it also increased the ventilatory response to acute hypoxia [13.6 +/- 1 vs. 11.2 +/- 0.7 l/min at 5 min of hypoxia, P = 0.03 vs. placebo (by ANOVA)]. Despite a larger minute ventilation and a smaller decrease in O(2) desaturation (83 +/- 1 vs. 79 +/- 2%, P = 0.003), the muscle sympathetic nerve response to hypoxia was similar between enoximone and placebo (123 +/- 6 and 117 +/- 6%, respectively, P = 0.28). In multivariate regression analyses, enoximone enhanced the ventilatory (P < 0.001) and sympathetic responses to isocapnic hypoxia. Hyperoxic hypercapnia and isometric handgrip responses were not different between enoximone and placebo (P = 0.13). Enoximone increases modestly the chemoreflex responses to isocapnic hypoxia. Moreover, this effect is specific for the peripheral chemoreflex, inasmuch as central chemoreflex and isometric handgrip responses were not altered by enoximone.


Subject(s)
Central Nervous System/drug effects , Chemoreceptor Cells/drug effects , Enoximone/pharmacology , Hypercapnia/physiopathology , Hyperoxia/physiopathology , Hypoxia/physiopathology , Peripheral Nervous System/drug effects , Phosphodiesterase Inhibitors/pharmacology , Reflex/drug effects , Adult , Apnea/physiopathology , Cardiac Output/drug effects , Central Nervous System/physiopathology , Chemoreceptor Cells/physiopathology , Cross-Over Studies , Enoximone/administration & dosage , Hand Strength , Hemodynamics/drug effects , Humans , Infusions, Intravenous , Male , Muscle, Skeletal/drug effects , Muscle, Skeletal/innervation , Peripheral Nervous System/physiopathology , Phosphodiesterase Inhibitors/administration & dosage , Pulmonary Ventilation/drug effects , Single-Blind Method , Sympathetic Nervous System/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...